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The mammalian genome is transcribed into large numbers of long noncoding RNAs (lncRNAs), but the
deﬁnition of functional lncRNA groups has proven diﬃcult, partly due to their low sequence conservation and
lack of identiﬁed shared properties. Here we consider positional conservation across mammalian genomes as
an indicator of functional commonality. We identify 665 conserved lncRNA promoters in mouse and human
genomes that are preserved in genomic position relative to orthologous coding genes. The identiﬁed ‘positionally
conserved’ lncRNA genes are primarily associated with developmental transcription factor loci with which they
are co-expressed in a tissue-speciﬁc manner. Strikingly, over half of all positionally conserved RNAs in this set
are linked to distinct chromatin organization structures, overlapping the binding sites for the CTCF chromatin
organizer and located at chromatin loop anchor points and borders of topologically associating domains (TADs).
These topological anchor point (tap)RNAs possess conserved sequence domains that are enriched in potential
recognition motifs for Zinc Finger proteins. Characterization of these noncoding RNAs and their associated
coding genes shows that they are functionally connected: they regulate each other’s expression and inﬂuence the
metastatic phenotype of cancer cells in vitro in a similar fashion. Thus, interrogation of positionally conserved
lncRNAs identiﬁes a new subset of tapRNAs with shared functional properties. These results provide a large
dataset of lncRNAs that conform to the “extended gene” model, in which conserved developmental genes are
genomically and functionally linked to regulatory lncRNA loci across mammalian evolution.
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1 Introduction
Long noncoding RNAs (lncRNAs) comprise the main
transcriptional output of the mammalian genome,
with recent surveys cataloguing approximately 60,000
lncRNA genes in humans compared to some 21,000
protein-coding loci (Iyer et al., 2015). While many
of these lncRNAs are transcribed by RNA Polymerase
II and are predominantly spliced and polyadenylated
in a similar manner to protein-coding genes, there are
currently no sequence or structural features that are
predictive of their biological functions.
The functions of only a small fraction of lncRNAs
have been experimentally tested, predominantly on an
ad hoc basis, revealing that they can exert diﬀerent
roles to regulate genome function and gene expression
at diﬀerent levels (Amaral and Mattick, 2008; Flynn
and Chang, 2014). From a mechanistic point of view,
lncRNAs can act both post-transcriptionally and at the
level of chromatin structure and transcription, where
they can aﬀect the genes in the immediate genomic
vicinity (in cis) and/or in other genomic locations (in
trans) to repress or promote expression. Well-studied
repressors include lncRNAs associated with imprinted
loci such as AIRN (Antisense IGF2R ncRNA) and
KCNQ1OT1 (KCNQ1 opposite strand/antisense tran-
script 1), which promote the silencing of genomically
associated genes in an allele-speciﬁc manner (Kanduri,
2015). Examples of activator RNAs include the lncR-
NAs HOTTIP (HOXA transcript at the distal tip)
and transcripts with “enhancer-like function” such as
ncRNA-a, which promote the transcription of neigh-
boring genes (Guil and Esteller, 2012; Lai et al., 2013;
Wang et al., 2011).
In contrast to coding genes, most lncRNAs do not
exhibit high levels of primary sequence conservation
across species (Carninci et al., 2005; Iyer et al., 2015).
In fact, the increasing catalog of these transcripts such
as AIRN and XIST (X inactive-speciﬁc transcript),
which have been extensively molecularly characterized,
indicate that they evolve under diﬀerent functional con-
straints and exhibit high evolutionary plasticity (Pang
et al., 2006). There are other indications as to what
some of these diﬀering constraints may be, including
the early observation that lncRNAs can have promot-
ers that exhibit higher conservation and that extends to
longer sequence stretches than observed for promoters
of coding genes (Carninci et al., 2005).
Using cDNA and EST genomic mapping, it has been
shown that some lncRNAs have highly conserved pro-
moters that are genomically localized in syntenic re-
gions, which are consistently associated with ortholo-
gous genes in diﬀerent species and these often have de-
velopmental functions (Dinger et al., 2008; Engstrom et
al., 2006). For example, the lncRNA SOX2OT (SOX2
Overlapping Transcript) has alternative syntenic tran-
scripts associated with highly conserved promoters in
all vertebrate groups, with similar expression patterns,
particularly in the central nervous system (Amaral et
al., 2009). Importantly, other characterized lncRNAs
that fall in the same category, such as HOTTIP, WT1-
AS and Evf2/Dlx6os (Dlx6 opposite strand transcript)
were demonstrated to participate in the regulation of
the associated genes (Dallosso et al., 2007; Feng et al.,
2006; Wang et al., 2011), suggesting a conserved func-
tional connection between lncRNAs and neighboring
genes. More recently, transcriptomic studies have ex-
panded these observations and shown that synteny is
observed for hundreds of lncRNAs across the genomes
of amniotes and beyond (Hezroni et al., 2015).
Here, we systematically characterize genomic posi-
tional conservation of lncRNAs in mammals and inves-
tigate whether this feature is indicative of their bio-
logical roles. We identify 1700 positionally conserved
lncRNAs, transcribed from 665 conserved syntenic pro-
moters and ﬁnd that they are predominantly associ-
ated with developmental genes, with which they are co-
expressed in a conserved tissue-speciﬁc manner. Char-
acterization of these RNAs shows that they can posi-
tively regulate their associated gene, can aﬀect cancer-
linked phenotypes in a similar fashion to the associated
gene, have conserved sequence motifs and are strongly
associated with chromatin loops, which contact en-
hancer regulatory sequences. This analysis provides
a rich resource for the in-depth characterization of the
ill-deﬁned family of lncRNAs and their relationship to
the structure and function of chromatin topological or-
ganization.
2 Results
2.1 Identiﬁcation of positionally conserved
RNAs in human and mouse
There is a paucity of information regarding the orga-
nization of lncRNAs into groups with common func-
tionality. Here we considered that the conserved posi-
tion of lncRNAs relative to coding genes may reﬂect a
basis for identifying common properties and for func-
tional indexing. We therefore set out to identify spliced
lncRNAs that are positionally conserved in mammalian
genomes. We compiled a comprehensive catalog of hu-
man and mouse transcripts based on 1) Gencode an-
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Figure 1: A: Workﬂow used for the identiﬁcation of pcRNAs. B: Schematic diagram showing the possible orientations of a pcRNA (red)
relative to a coding gene (blue). C: GO enrichment analysis of pcRNA-associated coding genes. The x-axis shows the enrichment
score, calculated as the number of pcRNA-associated genes in a given GO category divided by the total number of genes in the cat-
egory. The size of the points indicates the absolute number of pcRNA-associated genes in the given GO category. The color-coding
indicates the adjusted p-value.
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notation (Harrow et al., 2012); 2) human and mouse
RNA-sequencing (RNA-Seq) from six matched tissues
(brain, cerebellum, heart, kidney, liver and testis)
(Brawand et al., 2011); and 3) RNA-Seq data from
four similar human and mouse cell lines (embryonic
stem (ES), leukemia, lymphoblast and muscle cells)
produced by the ENCODE project (Supplementary
Table S1) (The ENCODE Project Consortium, 2012;
Djebali et al., 2012). In total, we processed 80 RNA-
Seq datasets and successfully mapped 2.6 billion reads.
Our analysis pipeline is designed for the comprehen-
sive identiﬁcation of human and mouse transcripts from
both Gencode and the RNA-Seq data, with evidence of
splicing, no overlap with coding exons in the same tran-
scriptional orientation and no signiﬁcant coding poten-
tial (Figure 1A). Promoter sequences of human lncR-
NAs were then aligned to the mouse genome to iden-
tify syntenic lncRNAs (see Supplementary Methods),
since it is known that the promoter of lncRNAs can
be conserved, even though the RNAs often show little
sequence conservation (Carninci et al., 2005). Syntenic
lncRNAs were deﬁned as positionally conserved if their
promoters were genomically associated with ortholo-
gous genes and produced spliced lncRNAs in the same
relative transcriptional orientation (either sense or an-
tisense relative to the coding gene) in both mouse and
human (see Supplementary Methods).
The resulting set of positionally conserved lncRNAs
(pcRNAs) comprises 1700 transcripts, including splic-
ing isoforms, associated with 665 unique conserved pro-
moters and a total of 626 orthologous coding genes
(Supplementary Table S2). The majority of pcR-
NAs (82%, 1401/1700 transcripts, transcribed from 595
independent promoters) were Gencode annotated hu-
man transcripts, while 299 (18%) represented novel
transcripts assembled from the RNA-Seq data. We also
found that a small number of pcRNAs (138, transcribed
from 32 independent promoters) overlapped syntenic
microRNA (miRNA) loci, likely representing primary
miRNA transcripts.
We classiﬁed pcRNAs into the following seven cate-
gories based on their genomic orientations relative to
the associated coding genes (Figure 1B): Antisense
(AS, direct overlap with the coding gene but tran-
scribed from the opposite strand), Bidirectional (BT,
transcribed in the opposite orientation with the tran-
scription start site (TSS) within 2kb upstream the
TSS of the coding gene), Overlapping (OLAP, partially
overlapping the coding locus in the same orientation,
with no overlap to coding exons and less than 50%
overlap with untranslated regions), and transcripts Up-
stream (US) or Downstream (DS) of the coding genes
in either sense (S) or antisense (AS) orientation.
The predominant category is Bidirectional tran-
scripts (42% of all pcRNAs), followed by Antisense
(18%), with all other categories similarly represented
(between 5% and 9%) (Supplementary Figure
S1A). On average, pcRNAs are 1.3kb long and have
3-4 exons (mean 3.6 exons per pcRNA), with most
having 2 exons (Supplementary Figure S1B,C). In
terms of genome distribution, most pcRNAs are prox-
imal to coding genes. However, the distance between
the pcRNA promoters and the TSS of the associated
coding genes varies according to the positional cate-
gory of the pcRNAs (Supplementary Figure S1D).
Approximately 70% of pcRNAs are within 12kb of the
associated genes. While BT, AS and OLAP promoter
positions are, as expected, closest (median TSS to TSS
distances of 215bp, 520bp and 35bp, respectively), pro-
moters of upstream and downstream transcripts are
usually much more distal (median TSS to TSS dis-
tances of 154kb (DS-S), 100kb (DS-AS), 44kb (US-
AS), and 49kb (US-S)). Despite being less conserved
then their associated coding genes, we found that hu-
man pcRNAs have on average 31% sequence identity
with their mouse counterparts (Supplementary Fig-
ure S1E).
2.2 Positionally conserved RNA genes are
associated with genes encoding
developmental transcription factors
Gene Ontology (GO) analysis of the 626 coding genes
with which pcRNAs are associated showed a very
strong enrichment for genes with roles in Regula-
tion of transcription from RNA polymerase II pro-
moter (GO:0045944 and GO:0000122, adjusted p-
values=1.2 × 10-15 and 8.5 × 10-10 respectively, Fig-
ure 1C and Supplementary Table S3). These
are transcription factors involved in Cell fate de-
termination (GO:0001709, adjusted p-value=0.00265)
and Developmental induction (GO:0031128, adjusted
p-value=0.00265), and central in the determina-
tion of a variety of speciﬁc developmental systems
and embryonic stages, such as gastrulation regula-
tion, stem cell maintenance and organ morphogenesis
(Supplementary Table S3). Notably, many of these
genes belong to major gene families containing regu-
lators of lineage speciﬁcation, such as SOX genes (in-
cluding SOX1, 2, 4, 9 and 21); FOX genes (FOXA2,
D3, E3, F1, I and P4); HOX genes (e.g. HOXA1,
A2, A3, A11, A13, B3, C5 and D8) and other home-
odomain genes, as well as several nuclear receptors,
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such as NR2E1, NR2F1 and NR2F2 (Supplementary
Table S3).
Coding genes associated with pcRNAs showed an
over-representation for developmental genes irrespec-
tive of their relative orientation to the associated
pcRNA. We also found that certain categories had spe-
ciﬁc enrichment relative to all pcRNA-associated cod-
ing genes (Supplementary Table S4). For exam-
ple, genes associated with bidirectional and overlapping
pcRNAs were found to be enriched for signal transduc-
tion and signaling pathways (such as IGF2, TGFB2
and PIK3R5) (Supplementary Table S4).
2.3 Positionally conserved RNAs have
similar tissue speciﬁc expression
patterns in mouse and human
To quantify the expression of pcRNAs and their as-
sociated protein-coding genes across the tissues and
cell types, we used publicly available RNA-Seq data.
As previously reported by us and others for lncRNAs
(Cabili et al., 2011; Derrien et al., 2012; Dinger et
al., 2008; Ravasi et al., 2006), pcRNAs have low av-
erage levels of expression when considered across all
tissues (Supplementary Figure S2A), and their ex-
pression proﬁles often peak in one or a few speciﬁc tis-
sues and/or cell lines (Figure 2A, Supplementary
Figure S2B,C).
We also found that pcRNAs exhibit signiﬁcantly
conserved expression patterns across mouse and hu-
man tissues (mean Spearman’s correlation 0.26, p-
value<10-6, Supplementary Figure S2D) and very
speciﬁc tissue expression signatures, with testis and
brain/cerebellum containing the largest complements
of tissue-speciﬁc pcRNAs (Figure 2A, Supplemen-
tary Figure S2E). Indeed, we identiﬁed numerous
expression clusters of pcRNAs with highly correlated
expression proﬁles and maximum expression in the
same tissue, suggesting that pcRNAs may have con-
served roles in tissue identity and cell type speciﬁ-
cation in mouse and human. Among the gene cate-
gories associated with tissue-speciﬁc pcRNAs expressed
in any given tissue, we observed enrichment for regu-
latory genes involved in developmental and diﬀerentia-
tion processes relevant to the particular tissue, such as
neural diﬀerentiation genes in brain and endoderm de-
velopmental genes in liver (Supplementary Figure
S3A-D).
2.4 Positionally conserved RNAs and
genomically associated coding genes
are co-expressed and co-induced
Expression of pcRNAs and associated genes showed a
signiﬁcant positive correlation when we analyzed RNA-
Seq proﬁles across tissues (mean Spearman rho 0.25,
p-value<10-6; Figure 2B), and in the majority of
cases this correlation does not appear to be depen-
dent on the proximity of the pcRNA to its coding gene
(Supplementary Figure S4A). We also observed
that pcRNAs have signiﬁcantly higher tissue speciﬁcity
than their associated coding genes (Supplementary
Figure S4B). This result was also conﬁrmed after tak-
ing into account the diﬀerent expression levels of pcR-
NAs and coding genes, indicating that the increased
tissue speciﬁcity of pcRNAs is not due to their lower
expression level (see Supplementary Methods and Sup-
plementary Figures S4C,D) . These data suggest
that pcRNAs and their corresponding coding genes are
often co-regulated in mouse and human. Indeed, ex-
pression analysis of diﬀerent pcRNAs in human NT2
(NTERA/D1) teratocarcinoma cells upon diﬀerentia-
tion with all-trans retinoic acid – a widely-used system
for regulation of Hox genes and ncRNAs (Sessa et al.,
2007) - shows that they have regulated expression and
are co-regulated with the associated coding genes, in-
cluding homeobox genes, NR2F1 and TBX2 (Figure
2C,D, Supplementary Figure S5). For instance,
HOXB6 and HOXB5/6-AS transcripts are expressed
in the same tissues and both can be induced when
we diﬀerentiate NT2 cells (Figure 2C,D), similarly to
the temporal co-induction seen with other coding/non-
coding pairs (Supplementary Figure S5) and remi-
niscent of the co-regulation that we previously observed
in diﬀerentiating mouse embryonic stem cells (Dinger
et al., 2008).
To validate these results and extend to a larger and
more diverse set of human and mouse tissues and cell
types, we used the Nanostring expression assay, which
provides a versatile platform for parallel single molecule
detection of targeted RNAs with high sensitivity and
speciﬁcity (Geiss et al., 2008). We designed a cus-
tom codeset to probe approximately 50 human and
mouse manually selected pcRNAs and associated or-
thologous protein-coding genes, across an RNA panel
of six matched human and mouse tissues. We also sam-
pled additional tissues and cells such as mouse eye,
spinal cord and embryonic stages; pluripotent cell lines
from both species at various time-points of diﬀerentia-
tion with retinoic acid, and a panel of 18 human cancer
cell lines (Supplementary Table S5).
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Figure 2: A: Heatmap showing the Euclidean distance between the expression proﬁles of human pcRNAs. The horizontal side bar reports
the tissue speciﬁcity score of pcRNAs. The vertical sidebar reports the tissues in which each pcRNA has maximal expression. B:
Density distribution of the Spearman’s correlation coeﬃcients between pcRNAs and corresponding coding genes in human tissues
and cell lines (mean Spearman’s rho 0.25, permutation test p-value <10-6). The dotted line shows the background distribution of
all pairwise Spearman’s correlations between pcRNAs and pcRNA-associated coding genes. Inset: Distributions of the Spearman’s
correlation coeﬃcients dived by the positional category of the pcRNA. C: Real time PCR data showing the expression of HOXB6
(blue) and HOXB5/6AS (red) in a panel of 7 human somatic tissues. The data is expressed relative to the expression of GAPDH;
the error bars indicate the standard error of the mean (SEM) across 3 technical replicate experiments. D: Real time PCR data
showing the expression of HOXB6 (left) and HOXB5/6AS (right) over 5 time-points of NT2 cells diﬀerentiation with retinoic acid
(RA). The data is expressed relative to the expression of B2M; the error bars indicate the standard error of the mean (SEM) across
3 replicate experiments. E: Nanostring expression proﬁles of FOXA2 and FOXA-DS-S across human (left) and mouse (right)
tissues. The points indicate the mean value of two technical replicates, while the vertical bars report the value of each replicate.
F: Heatmap showing Spearman’s correlation coeﬃcients between the expression of human and mouse FOXA2 and FOXA-DS-S
transcripts. G: Histone modiﬁcation proﬁles of pcRNA promoters (top) and promoters of 1000 random Gencode coding genes
(bottom) based on ChIP-Seq data by the ENCODE project on H1-hESCs. The lines represent the mean ChIP-Seq coverage. H:
Transcription factor binding patterns in promoters of pcRNAs (left) and their associated coding genes (right). The heatmaps
present the distribution of experimentally validated TF-binding sites from ENCODE 2,216 ChIP-seq experiments (y-axis), showing
strong co-relations between the promoters of pcRNAs (x-axis) and their corresponding coding genes. The black bar indicates the
binding pattern of the CCCTC-binding factor (CTCF).
Using this approach we conﬁrmed common
co-expression of pcRNAs and associated genes
(Supplementary Figure S6A,B), as well as con-
servation of expression between mouse and humans
pcRNAs across diﬀerent tissues (Supplementary
Figure S6C). For example, FOXA2 and its associ-
ated pcRNA FOXA2-DS-S exhibit very similar ex-
pression proﬁles across tissues both in human and
mouse (Figure 2E), with Spearman correlation co-
eﬃcients in the range 0.52-0.73 (Figure 2F). We
observed similar results for HNF1A and its pcRNA
HNF1A-BT1/2 (Supplementary Figure S6D-G).
Additionally, we found that pcRNAs often form clus-
ters of co-expression with functionally related tissue-
speciﬁc regulatory genes (Supplementary Figure
S7A,B). For instance, two connected clusters are com-
prised of transcription factors that are master regula-
tors of endoderm - in particular liver cell diﬀerentiation
(HNF1A, FOXA2/HNF3B and HNF4A) (Costa et al.,
2003; Odom et al., 2006) – and associated pcRNAs.
These data suggest that pcRNAs share regulatory el-
ements and/or have a role in the regulation of their
neighboring protein-coding genes.
To investigate the principles of pcRNA regula-
tion, we ﬁrstly inspected chromatin modiﬁcation pro-
ﬁles around their TSS. Using the ENCODE genome-
wide datasets for diﬀerent human cell lines (EN-
CODE tier 1 lines: GM12878, H1-hESC, HSMM and
K562) (The ENCODE Project Consortium, 2012; Hoﬀ-
man et al., 2013), we identiﬁed a clear enrichment
in H3K4 di- and tri-methylation (H3K4me2/3) and
H3K9 and H3K27 acetylation (H3K9ac, H3K27ac)
(Figure 2G and Supplementary Figure S8), as
well as H3K27 tri-methylation (H3K27me3) and biva-
lent marks speciﬁcally for pcRNA promoters in ES cells
(Supplementary Figure S9). At the same time,
we observed only low levels of H3K4me1 in all the
cell types analyzed. These proﬁles are indicative of
RNA Polymerase II promoters, are similar to those ob-
served for protein-coding genes (Supplementary Fig-
ure S8), and are not indicative of enhancers, suggest-
ing that the pcRNA transcripts are not reﬂective of
typical enhancer RNAs (eRNAs) produced from en-
hancer regions. Interrogation of the FANTOM5 Con-
sortium database (Andersson et al., 2014), containing
comprehensive annotations of over 40,000 enhancer re-
gions, identiﬁed the promoters of only three pcRNAs as
enhancers (associated with GATA2, HES1 and KLF4)
(data not shown).
2.5 Identiﬁcation of topological anchor
point (tap)RNAs
To obtain insights into the regulation of pcRNA and
associated genes, we analyzed their promoters for tran-
scription factor (TF) binding proﬁles. Using TF ChIP-
seq peaks from the ENCODE project (The ENCODE
Project Consortium, 2012; Wang et al., 2012), we ob-
served a highly concordant pattern of occupancy in the
promoters of pcRNAs and associated genes (Pearson
correlation coeﬃcient = 0.67, p-value < 1 × 10-3, Fig-
ure 2H). Such general co-regulation was further sup-
ported by the analysis of predicted TF binding motifs
in both promoters (Pearson correlation coeﬃcient =
0.63, p-value < 1 × 10-3) (Supplementary Figure
S10). The proﬁles show groups of pcRNAs and cod-
ing genes as potential targets of the same general and
developmental factors, suggesting that the coordinated
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Figure 3: A: Bar chart showing the proportion of pcRNAs, pcRNA-associated coding genes, Gencode lncRNAs and Gencode coding genes
with a CTCF peak (based on Encode ChIP-Seq data) overlapping their promoter. The p-values reported were calculated with
hypergeometric tests. Right: CTCF peaks coverage of loci of pcRNAs, pcRNA-associated coding genes, Gencode lncRNAs and
Gencode coding genes. The plots report the loci from 20kb upstream of the transcription start site (TSS) to 20kb downstream of
the transcription end site (TES). For visualization purposes these proﬁles show the coverage of a random sample of 5000 Gencode
lncRNAs and 5000 random Gencode coding genes. B,C: Aggregation density plots showing the distribution of the TSS of pcRNAs
(red) and lncRNAs (orange) relative to chromatin topological domains (B) and chromatin loop anchor points (C). Domains and
loop anchor points were deﬁned based on HiC data. D: Venn diagram showing the number of pcRNAs whose promoter overlap a
Loop Anchor Point (purple) or a Domain Boundary (green) E: Schematic representation of the TBX2 locus showing the pcRNA
TBX2-BT and chromatin loops deﬁned by HiC data (Rao et al., 2014). Modiﬁed from a screenshot of the UCSC genome browser.
F: Bar chart showing the proportion of pcRNAs, pcRNA-associated coding genes, Gencode lncRNAs and Gencode coding genes
with a HiC loop overlapping their promoter. The p-values reported were calculated with hypergeometric tests. Right: HiC loops
coverage of loci of pcRNAs, pcRNA-associated coding genes, Gencode lncRNAs and Gencode coding genes. The plotted genomic
regions encompass the loci from 20kb upstream of the TSS to 20kb downstream of the transcription end site (TES). For visualization
purposes these proﬁles show the coverage of a random sample of 5000 Gencode lncRNAs and 5000 random Gencode coding genes.
G: Cumulative distribution plot showing the percentage of distal genomic regions in contact with pcRNA promoters (y-axis) as
a function of the fraction of length of loop-end annotated as Enhancer (left) or Promoter (right). For example, the “>0.4” point
(x-axis) of the red line in the ﬁrst plot indicates that 37% (y-axis) of the distal genomic regions in contact with pcRNA promoters
is annotated as Enhancer for 40% or more of their length. Promoters of pcRNAs are signiﬁcantly more often in contact through
loops with enhancer elements compared to generic Gencode lncRNAs (p-value 2.85x10-6). The indicated p-values were calculated
using the Kolmogorov-Smirnov test.
expression between the pairs is largely due to the shar-
ing of transcriptional regulatory elements.
The transcription factor occupancy analysis showed
a striking enrichment of binding for CCCTC-binding
factor (CTCF) in the regions adjacent to the TSSs
of most pcRNAs (72% of pcRNA promoters contain a
CTCF peak, Figure 2H,3A), and an enrichment with
respect to other spliced lncRNAs and protein coding
genes (Figure 2H,3A).
The genome is highly structured and gene expression
inﬂuences and is inﬂuenced by the topological organi-
zation of the chromatin (Cavalli and Misteli, 2013).
This organization is largely dictated by CTCF binding
and includes individual chromatin loops and distinct
regions with increased frequencies of genome looping
contacts deﬁned as topologically associating domains
(TADs) (Rao et al., 2014). We thus interrogated high
resolution, genome-wide topological maps (Rao et al.,
2014) to establish the relative positioning of pcRNAs
and their coding genes relative to genomic loops.
We found that pcRNAs are preferentially located at
the boundaries of TADs and chromatin loop contact
points (or “loop anchor points”) (Figure 3B,C) (Rao
et al., 2014). In particular, we noticed that a remark-
able proportion of pcRNAs (912 out of 1700 pcRNAs
isoform TSSs, 54%) have a promoter that overlaps a
TAD boundary (446 pcRNAs) and/or directly inter-
sects a loop anchor point (764 pcRNAs, Figure 3D).
For example, the pcRNA TBX2-BT and other pcR-
NAs associated with important developmental genes lie
at TAD boundaries and overlap multiple loop anchor
points (Figure 3E, Supplementary Figure S11).
Strikingly, the proportion of pcRNA promoters that
overlap a TAD boundary or a loop anchor point is sig-
niﬁcantly higher than that of Gencode spliced lncRNAs
(p-value=3.4 × 10-23, Figure 3F, Supplementary
Figure S12A,B). Similarly, the promoters of pcRNA-
associated coding genes are also signiﬁcantly enriched
in TAD boundaries or loop anchor points compared to
other protein coding genes, although to a lesser extent
than pcRNAs. Interestingly, we found that the location
where loop anchor points are found around and within
pcRNAs peaks distinctively at their TSS (Figure 3F),
consistent with the observed positioning of CTCF bind-
ing sites and pcRNA TSS distribution within TADs and
loops (Figure 3A-C).
Given this marked and precise association of their
promoters with loop anchor points, we deﬁned this
group of 764 pcRNAs as ‘topological anchor point
RNAs’ (tapRNAs), representing the subset of pcRNAs
whose promoters overlap a loop anchor point (Figure
3D).
To gain further insights into the function of these
promoter loops we analyzed the genomic regions they
contact through looping. Based on the chromatin state
segmentation by HMM from ENCODE/Broad for 9
cell lines (Ernst et al., 2011), we found that these
loop anchor points are marked by multiple chromatin
states and that a remarkable proportion appears to
overlap marks of active transcription and/or enhancers
(Supplementary Figure S12C). Interestingly, pcR-
NAs are signiﬁcantly more likely to be in contact with
enhancer elements through such loops, compared to
Gencode lncRNAs (p-value=2.85 × 10-6; Figure 3G).
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This is not the case for the contact with promoter el-
ements, transcribed regions or other HMM deﬁned ge-
nomic regions (Figure 3G, Supplementary Figure
S12D). These results indicate that the tapRNAs that
are at loop anchor points are likely to be associated
with enhancer sequences present on the other end of
the loop.
2.6 Conserved domains and motifs in
tapRNAs
In order to establish any commonality of sequence that
may provide clues to the function of tapRNAs, we
explored their sequence conservation by direct RNA
alignment. We found that 73% of tapRNAs show high
conservation in patches of sequence between human
and mouse (see Supplementary Methods), while the
other 27% lack these highly conserved patches (Figure
4A). We divided the conserved 73% into (a) high- (b)
medium- and (c) low-conservation-region tapRNAs and
carried out a GO enrichment analysis on their associ-
ated coding genes. In all cases, the predominant cate-
gory of genes associated with these tapRNAs was linked
to development. In contrast, the 27% of tapRNAs
with no highly conserved segments (d) were associated
with genes showing no strong enrichment in functional
categories. These data suggest that tapRNAs asso-
ciated with developmental transcription factor genes
have more signiﬁcant sequence conservation than other
tapRNAs. Indeed, tapRNAs as a class show more se-
quence conservation than lncRNAs in general (Figure
4B).
The fact that we can detect conserved sequence
domains within the tapRNA class (Figure 4C),
prompted us to examine whether there are any se-
quence motifs in common between them. Motif enrich-
ment analysis identiﬁed 32 8-mer motifs that were sig-
niﬁcantly more represented in the conserved domains of
tapRNAs relative to non-conserved sequences (Figure
4D, Supplementary Figure S13). Closer inspection
indicated that these 32 motifs were related and could be
sub-categorized into 10 consensus motifs, which were
reminiscent of transcription factor binding sites. All
the 10 motifs have the potential to bind transcription
factors, the predominant type being factors with Zinc
Finger (ZF) domains (Figure 4D). Nevertheless, in-
spection of the available ChIP-seq data did not de-
tect proteins of this category binding on the DNA
corresponding to these regions in tapRNAs (data not
shown). This raises the possibility that the motifs seen
within the conserved domains of tapRNAs represent
distinct RNA motifs.
Given that many tapRNA genes are at chromatin
loop end points which have enhancers at the other end
of the loop, we inspected whether the motifs enriched in
conserved domains of tapRNAs are also enriched within
the enhancer sequences found at the other end of the
loop. We show (Figure 4D,E) that three out of the ten
motifs enriched in tapRNAs are also enriched within
enhancers on the other end of the loop anchor point.
Strikingly, these three motifs are all motifs that have
the potential to bind ZF proteins, including binding
motifs for proteins associated with chromatin looping
and enhancer function such as Znf143 and Zic2 (Hei-
dari et al., 2014; Luo et al., 2015; Xie et al., 2013),
which may be important for the function or regulation
of these tapRNAs.
2.7 Functional analysis of positionally
conserved RNAs
Co-regulation of gene expression. Given that pcR-
NAs and their neighboring gene are co-expressed in a
tissue-speciﬁc manner, we investigated their ability to
regulate each other’s expression. First, we tested this
hypothesis on a set of liver speciﬁc master regulators,
FOXA2 and HNF1A, and their associated pcRNAs.
ChIP-sequencing data (Ballester et al., 2014; Down et
al., 2011) shows that the promoters of the FOXA2 gene
and FOXA2-DS-S pcRNA are occupied by a similar
set of transcription factors, and importantly, the same
factors (FOXA1, FOXA2, HNF4A and HNF6) that
are key regulators of liver diﬀerentiation (Figure 5A,
Supplementary Figure S14). This again suggests
that the mechanism of co-expression and co-induction
is due, at least in part, to speciﬁc factors concomitantly
regulating the expression of both the coding and non-
coding transcripts.
We next investigated whether the FOXA2-DS-S
pcRNA can aﬀect the expression of the associated cod-
ing gene, ﬁnding that FOXA2-DS-S is necessary for the
full expression of the FOXA2 gene (Figure 5B, Sup-
plementary Figure S15A), since its down-regulation
by RNA interference results in the reduction of FOXA2
expression in Huh7 liver cells (Figure 5B), A549 lung
cells (Supplementary Figure S15A) and HepG2
liver cells (data not shown). Interestingly, knock-down
of FOXA2 with a validated siRNA also leads to the
down-regulation of FOXA2-DS-S (Figure 5B, Sup-
plementary Figure S15A).
These results indicate that FOXA2 not only
auto-regulates by binding its own promoter
(Supplementary Figure S14), but that it also af-
fects the expression of the associated pcRNA. At the
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Figure 4: A: Clustered heatmap of conserved domains in transcribed tapRNAs. Aligned sequences (shown in red) in 279 non-redundant
tapRNA isoforms are clustered (Euclidean distance). Sixteen minor clusters were identiﬁed and grouped into four major clusters.
Each minor cluster’s centroids are shown with the number of tapRNAs belonging to each minor cluster. 39 tapRNAs (top group:
blue) have more than 73% conserved domain in their transcribed sequences. Functional category annotation search ﬁnds that
tapRNAs of top group are highly related to developmental proteins or Homeobox proteins. In contrast, 76 tapRNAs of the bottom
cluster (grey) do not have any sequence conservation and do not show signiﬁcant common functionality. There are also some
minor groups in which position speciﬁc conservations are clearly present (e.g. 5’-end speciﬁc or 3’-end speciﬁc). B: Comparison
of conservation between tapRNAs, lncRNAs and protein coding genes. The curves are Kernel Density Estimation (KDE) of
conservation scores calculated from the phastCons multiple alignments of 100 vertebrate species. C: Example of conserved domains
in a pcRNA. Identical sequence alignments (conserved domains) between human and mouse HNF6-US-S tapRNAs are represented
in red, with RNA sequence alignments shown. D: Enriched TF-binding motif in both conserved domain of tapRNAs and enhancer
region of loop anchor point. 32 signiﬁcantly enriched 8-mer motifs (see Supplementary Figure S13; p-value 1 × 10-4) in
conserved domains in tapRNAs are identiﬁed and clustered into 10 consensus motifs. De novo motif analysis discovers known TFs
with matching binding consensus motifs. Seven out of ten consensus motifs are part of binding motifs of Zinc Finger proteins.
The other three consensus motifs are part of binding motifs of developmental regulatory proteins. E: Extended motif search in
enhancer regions of the other end of loop anchor points found signiﬁcant enrichments of Zinc Finger protein motifs.
same time, the associated pcRNA is necessary for the
expression of the FOXA2 gene in diﬀerent cell types,
thus providing a positive feedback-loop and suggesting
inter-dependence. This also raises the possibility that
the pcRNA acts locally, in cis, in order to mediate
its eﬀect. Microarray analysis of the global transcrip-
tional eﬀects of FOXA2-DS-S or FOXA2 knock-down
showed a large overlap in the repertoire of aﬀected
genes (Figure 5C,D). This suggests that the major
target for FOXA2-DS-S is the FOXA2 gene, although
there may be additional direct targets yet to be identi-
ﬁed. These ﬁndings were recently independently sup-
ported by the cis-regulation of FOXA2 in diﬀerentiat-
ing deﬁnitive endoderm cells by FOXA2-DS-S (termed
in this study as DEANR1, or ‘deﬁnitive endoderm-
associated lncRNA1’), indicating that this lncRNA
regulates FOXA2 in diﬀerent endoderm-derived tis-
sues (Jiang et al., 2015).
We also obtained similar results for two other
tested pcRNAs in diﬀerent cell lines (POU3F3-BT and
NR2F1-BT) and also with a second liver factor HNF1A
(Supplementary Figures S6H and S15A-D). In
each of these cases, knock-down of the pcRNA reduces
the expression of the associated coding gene. Inter-
estingly, knock-down of HNF1A-BT1 reduces the ex-
pression of HNF1A (Supplementary Figures S6H)
but ectopic over-expression of full-length HNF1A-BT
in human liver cells had no eﬀect on the associated
gene, even though very high levels of over-expression
were achieved (data not shown), again suggesting a cis-
based context-dependent mode of regulation.
Involvement in cancer. The Nanostring analysis
of the cancer cell panel also demonstrated spe-
ciﬁc expression of pcRNAs, including many of the
tapRNAs, and associated genes in diﬀerent cancer
lines (Supplementary Figure S16A-E). lncRNAs
are emerging as important players in disease (Ama-
ral et al., 2013; Balbin et al., 2015) and many genes
with roles in development have been previously linked
to cancer and other disorders (Dickerson et al., 2011).
We therefore investigated the possible involvement of
diﬀerent pcRNAs in disease, speciﬁcally cancer. To
further explore this association, we ﬁrst performed a
meta-analysis of the expression of pcRNAs in normal
versus tumor samples in 63 microarray studies. After
re-annotating the microarrays to identify probes tar-
geting pcRNAs, we identiﬁed 203 pcRNAs signiﬁcantly
diﬀerentially expressed in tumors compared to normal
tissues (Figure 6A, Supplementary Table S6) (see
Supplementary Methods). These included known cases
of lncRNAs involved in diﬀerent cancers, such as GAS5,
DLEU2, PART1 and MEG3 (Pickard and Williams,
2015).
Close inspection of speciﬁc pcRNA-gene pairs with
altered expression in primary tumors showed that
a number of pcRNAs are consistently down- or
up-regulated in cancer compared to normal tissues
(Supplementary Table S6). For example, FOXA2
and FOXA2-DS-S were found signiﬁcantly down-
regulated in lung tumor compared to normal samples
(p-value 3 × 10-16 and 2 × 10-22 respectively), eﬀec-
tively separating tumor samples from controls (Figure
6B). Recent studies have correlated reduced FOXA2
expression in hepatocellular carcinoma (HCC) with
worse clinical outcome and identify this transcription
factor as a tumor suppressor and inhibitor of epithelial-
to-mesenchymal transition (EMT) in human lung can-
cers (Tang et al., 2011; Wang et al., 2014b). Here,
our data also suggest the implication of the pcRNA
FOXA2-DS-S in this process (Figure 6B).
To investigate whether the FOXA2-DS-S pcRNA has
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Figure 5: A: Screenshot from the Dalliance genome browser (Down et al., 2011) showing the FOXA2 locus with tracks displaying coverage
data for ChIP-Seq experiments for Pol2, FOXA1, FOXA2, HNF4A, HNF6 and CEBPA. The ChIP-Seq tracks were produced by
the ENCODE project on HepG2 cells. B: Real Time PCR data showing the expression of FOXA2 and FOXA2-DS-S in Huh7 cells
upon knock-down. Si1- and si2- FOXA2-DS-S indicate two diﬀerent, non-overlapping siRNAs designed against FOXA2-DS-S.
The data is expressed relative to the expression of the control transfected with scrambled siRNAs; the error bars indicate the SEM
across three replicate experiments. C: Venn diagram showing the number of signiﬁcantly diﬀerentially expressed genes (adjusted
p-value <0.05 and log2 fold change > or < 1.25) in the microarray experiment on Huh7 knock-down of FOXA2 or FOXA-DS-S. D:
Heatmap showing microarray data upon knock-down of FOXA2 or FOXA-DS-S in Huh7 cells. The color-scale indicates normalized
intensities (z-score). The heatmap contains all genes that were signiﬁcantly altered (adjusted p<0.05) upon knock-down of either
FOXA2 or FOXA-DS-S. The scatter plots in the lower part of the panel show GO enrichment data for genes that were signiﬁcantly
down (left) or up-regulated (right) in either siFOXA2 or siFOXA-DS-S.
a potentially causative eﬀect in cancer, we knocked-
down FOXA2-DS-S in Huh7 and A5A9 cells (Figure
6C, Supplementary Figure 15E). A dramatic in-
crease in both cell invasion and migration capacity was
observed, supporting a tumor suppressor function for
FOXA2-DS-S transcripts similar to the reported role
of FOXA2 in cancer cells (Basseres et al., 2012; Tang
et al., 2011) (Figure 6C, Supplementary Figure
15E). These data further support the close functional
link between the pcRNA and its associated gene. The
fact that the FOXA2-DS-S pcRNA has the same eﬀect
on the phenotypic characteristics of cancer cells as its
associated gene, is consistent with its positive eﬀect on
the expression of FOXA2 and the observation that it
regulates a similar cohort of genes (Figure 5C,D).
Finally, we also investigated the role of two other
pcRNA-gene pairs in invasion and migration charac-
teristics of cancer cells. We found that knock-down of
NR2F1-BT and NR2F1 or POU3F3-BT and POU3F3
similarly reduced the invasion/migration potential of
U251MG glioblastoma and U2OS osteosarcoma cells
(Supplementary Figure S15F-H). Thus, in the case
of pcRNAs NR2F1-BT and POU3F3-BT, their eﬀect
on cell invasion/migration suggests that they, like their
associated gene, may have oncogenic roles in these cells.
Taken together these data highlight the fact that cer-
tain pcRNAs can be considered as potential targets for
cancer and that their expression pattern may act as a
marker for the disease.
3 Discussion
3.1 Positional conservation identiﬁes
lncRNAs with common characteristics
linked to developmental genes
In this work, we systematically identify, on a genome-
wide scale, lncRNAs with conserved promoters in
mouse and human that are positionally conserved in
respect to neighboring coding genes. We catalogue 665
lncRNA promoters that are linked to 626 coding genes
and deﬁne these as positionally conserved. This anal-
ysis has identiﬁed a subset of lncRNAs with a close
relationship to a very speciﬁc cohort of neighboring
protein-coding genes, predominantly comprised of tran-
scription factors with well-established roles in develop-
ment.
Our analysis of positionally conserved lncRNAs
and their associated developmental transcription fac-
tors has identiﬁed common characteristics within this
group, which indicate that they are (a) expressed in
the same restricted tissues in mouse and human and
(b) co-induced when cells are stimulated with a diﬀer-
entiation signal, (c) have promoters bound by similar
transcription factors, (d) can aﬀect each others expres-
sion, (e) aﬀect invasion and migration of cancer cells in
similar ways, and (f) are part of a new subclass of lncR-
NAs, which are positioned at topological anchor points
(tapRNAs) and have a speciﬁc set of motifs enriched
within their conserved sequence.
Our dataset encompasses hundreds of previously
uncharacterized positionally conserved RNAs and in-
cludes a few lncRNAs that have been studied by others
on a case-by-case basis (e.g. HOTTIP (HOXA13-AS),
HOTAIRM1 (HOXA1-AS), NKX2-1-AS and FOXA2
(DEANR1, FOXA2-DS-S)) (Balbin et al., 2015; Deng
et al., 2016; Jiang et al., 2015; Wang et al., 2011; Zhang
et al., 2009). In all these studies the pcRNAs were
shown to regulate developmental genes in diﬀerent bio-
logical contexts, in a manner implying local regulation.
Our investigation of positionally conserved RNAs, as
well as recent analysis of syntenic RNAs deﬁned by oth-
ers (Amaral et al., 2009; Dinger et al., 2008; Hezroni
et al., 2015), highlights a common grouping of lncR-
NAs that have close functional connections with devel-
opmental transcription factors. Given this spatial and
functional connection, in this work we have annotated
pcRNAs using a systematic nomenclature that reﬂects
the orientation of the pcRNA relative to the associated
coding gene. We believe that this catalogue will be
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Figure 6: A: Heatmap showing pcRNAs diﬀerentially expressed in cancer microarray studies. Student t-test (p-value < 0.005 and fold-change
> 1.25) was used to identify pcRNAs (columns) that were up (red) or down-regulated (blue) in tumors compared to normal tissues
(rows) (see Supplementary Table S6). Examples of pcRNAs associated with speciﬁc loci are shown. B: Spearman correlation
between the expression of FOXA2 and FOXA2-DS-S in lung cancers (GSE18842 dataset). Tumor and normal individual samples
are represented as blue and red dots, respectively. Boxplots on the right show that both transcripts are down-regulated in tumor
compared to normal samples (Student’s t-test p-values are indicated). C: Invasion and migration assay analysis of Huh7 cells upon
knock-down of FOXA2-DS-S using two diﬀerent siRNAs (si1 and si2) compared to negative control siRNA.
a valuable resource in the individual characterization
of these important coding genes and their associated
non-coding RNA genes.
3.2 Co-regulation of positionally conserved
RNAs and developmental genes
Our analysis shows that pcRNAs and their associated
coding genes are co-expressed in a tissue speciﬁc man-
ner and co-induced after treatment with diﬀerentiating
agents, consistent with previous observations by us and
others that show co-regulation of lncRNAs and neigh-
boring genes in diﬀerent species (e.g. (Cabili et al.,
2011; Dinger et al., 2008; Goﬀ et al., 2015; Hezroni
et al., 2015; Mercer et al., 2008)). The fact that these
lncRNAs and associated coding genes have similar tran-
scription factor binding proﬁles within their promot-
ers (Figure 2H and Supplementary Figure S10),
and that these transcription factors can be tissue spe-
ciﬁc (Figure 5A, Supplementary Figure S13), pro-
vide some insight into the underlying mechanism. As
an example we have analyzed the liver speciﬁc gene
FOXA2 and its pcRNA FOXA2-DS-S. The promot-
ers of each of these are bound by liver speciﬁc factors,
such as HNF4A, HNF6 and FOXA2 itself. Consis-
tent with this, we ﬁnd that the transcription factor
FOXA2 can regulate both its own transcription and
that of the FOXA2-DS-S pcRNA. This example indi-
cates a mechanism by which one tissue speciﬁc factor
(FOXA2) can regulate both its own coding gene and
the associated pcRNA in a positive feedback loop to
exert co-expression in liver cell lines.
We have investigated the regulation of FOXA2 by
the FOXA2-DS-S pcRNA, and we see a positive eﬀect
on its expression levels. This positive regulatory ef-
fect could be extended to other pcRNAs and diﬀerent
cell types, in line with previous reports (e.g. (Jiang et
al., 2015) and references above). These results do not
exclude the possibility that pcRNAs may also have an
eﬀect on other neighboring or distal genes (in trans), or
that the regulation is repressive for gene expression, as
is the case for imprinted lncRNAs and other transcripts
(Goﬀ et al., 2015; Guil and Esteller, 2012; Kanduri,
2015). In addition, previous studies have shown that
genetic removal of lncRNA loci only in some cases aﬀect
the expression of neighboring genes in speciﬁc develop-
mental stages in vivo, suggesting that these loci are
not required for cis-regulation, although mechanisms
such as genetic compensation and robustness may be
involved (Rossi et al., 2015). Nevertheless, the func-
tional evidence presented and the numerous cases of
pcRNA positive correlation of expression with the as-
sociated gene in both mouse and human support the
hypothesis that positive and local regulation is an im-
portant mode of pcRNA regulation.
3.3 Positionally conserved RNAs and
cancer
Many developmental genes are implicated in cancer,
either positively or negatively. The expression analy-
sis of pcRNAs in primary cancers indicates that they
are over- or under-expressed in particular types of can-
cer, consistent with other studies (Balbin et al., 2015;
Iyer et al., 2015). Importantly, we show here that ma-
nipulation of the levels of a pcRNA has an eﬀect on
the metastatic characteristics of cancer cells in vitro.
These phenotypic eﬀects can be either positive or neg-
ative, but in each tested case the associated coding gene
and the pcRNA have a similar eﬀect on the metastatic
characteristic of cancer cells. Collectively, these data
suggest that pcRNAs have the potential to be causally
linked with the disease, and that the coding gene they
are associated with is a key target. We cannot exclude
the possibility that other targets of diﬀerent pcRNA
are drivers of the cancers. However, pcRNAs or the
pathways that regulate them may represent targets for
therapeutic intervention given their highly speciﬁc ex-
pression and alteration in particular cancers.
3.4 Topological anchor point RNAs
(tapRNAs)
The most striking feature of positionally conserved
RNAs is their enrichment in tapRNAs, deﬁned as
RNAs found at chromatin loop anchor points. These
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architectural landmarks are commonly occupied by the
CTCF boundary factor (Rao et al., 2014) and indeed
we ﬁnd an enrichment of CTCF binding in the promot-
ers of pcRNAs.
The presence of genes within chromatin loops has
already been proposed as an indication of increased
and coordinated expression and, although many such
loops do not show tissue speciﬁcity, other topology-
dependent events or ﬁner-scale topological contacts
likely regulate tissue-speciﬁc and ﬁne-tuned expres-
sion (Dowen et al., 2014; Lonfat et al., 2014; Rao et
al., 2014). LncRNAs are rapidly emerging as impor-
tant targets and actors in the regulation of genome
topology and nuclear architecture (Rinn and Guttman,
2014). These include lncRNAs whose functions are reg-
ulated by CTCF and chromatin looping structures (e.g.
(Engreitz et al., 2013; Maass et al., 2012; Sopher et
al., 2011; Spencer et al., 2011; Yang et al., 2016)),
but also well-characterized pcRNAs such as XIST
and an increasing number of more recently identiﬁed
cis- and trans-acting lncRNAs such as FIRRE, TSIX,
KCNQ1OT1, CCAT1-L, RUNXOR, IRAIN, ncRNA-
a, HoxBlinc and HOTTIP, which have been shown
to inﬂuence topological domains and chromosome con-
formation, for example by modulating the binding of
transcription factors, Mediator and CTCF complexes
(Deng et al., 2016; Hacisuleyman et al., 2014; Kung et
al., 2015; Lai et al., 2013; Minajigi et al., 2015; Sun et
al., 2014; Wang et al., 2014a; Wang et al., 2011; Xiang
et al., 2014; Yang et al., 2015; Zhang et al., 2014).
The ﬁnding that over 50% of positionally conserved
RNAs in our dataset are tapRNAs suggests that these
promoters and transcripts are more generally connected
to the structure and function of chromatin architectural
domains. This is especially relevant given the robust
conservation of chromatin conformation in syntenic re-
gions, in which conserved CTCF-Cohesin binding sites
are enriched at the borders of topological domains (Vi-
etri Rudan et al., 2015). In addition, important devel-
opmental genes are positioned and regulated at such
boundaries (Fabre et al., 2015) and these structures
can be especially implicated in developmental diseases
and cancer (Hnisz et al., 2016; Ibn-Salem et al., 2014;
Katainen et al., 2015; Lupianez et al., 2015; Maass
et al., 2012). The mechanisms may involve the con-
served tapRNA promoters present at the boundaries,
as many of these harbor highly conserved sequences
that potentially act as cis-regulatory elements. These
are exempliﬁed by the promoters of SOX2OT and other
pcRNAs associated with developmental genes, such as
Dlx1as and Evf1/2 (Amaral et al., 2009; Bond et al.,
2009; Dinger et al., 2008; Feng et al., 2006), although
conserved promoters and lncRNA loci may exhibit both
DNA- and RNA-dependent regulatory functions (Bond
et al., 2009). TapRNAs themselves could be either in-
ﬂuencing the formation of a topological anchor point or
be expressed at that precise location in order to aﬀect a
local function in a cell-type speciﬁc manner (although
these alternatives are not mutually exclusive).
Moreover, our observation that enhancers are of-
ten found on the other end of the loop containing a
tapRNA may be relevant to the mechanism of action
of these transcripts. Looped chromatin structures form
discrete chromatin domains and regulatory “neighbor-
hoods” that inﬂuence the local regulation of develop-
mental and cell-identity genes, tissue-speciﬁc enhancers
and other regulatory elements (Dowen et al., 2014;
Narendra et al., 2015). Since CTCF brings together
contact points on both side of a loop, the tapRNA can
be in close proximity to enhancers and thereby con-
tribute to enhancer regulation in a number of ways.
TapRNAs may directly deliver or remove proteins nec-
essary for looping and enhancer function; and interact
with DNA elements at the enhancer or with eRNAs
transcribed from these (Arner et al., 2015; Kim et al.,
2015; Pnueli et al., 2015; Sigova et al., 2015). These
diﬀerent potential mechanisms of action warrant ex-
perimental validation, and may be mediated by speciﬁc
sequence motifs within tapRNAs, as discussed below.
3.5 Conserved domains and motifs within
tapRNAs
Analysis of sequence conservation among tapRNAs has
shown that this subclass of RNAs is more conserved
than the bulk lncRNAs. Within the conserved se-
quences of tapRNAs, ten degenerate motifs were par-
ticularly enriched. These are similar to motifs for the
binding of transcription factors, predominantly of the
C2H2 Zinc Finger (ZF) family. Interestingly, ZF do-
mains of the C2H2 family have the ability to bind both
DNA and RNA (Brown, 2005). Thus these motifs may
represent part of the common functional characteristics
of tapRNAs, which could involve interaction with ZF
proteins or alternatively, base pairing with homologous
RNA or DNA sequences.
We ﬁnd that ZF motifs within tapRNAs are also en-
riched at enhancer sequences at the other end of the
loop. For example, one of these enhancer DNA motifs
(for the ZF protein ZIC2) has been shown to act as a
repressor of enhancer activity in a developmental con-
text (Luo et al., 2015). This raises the possibility that
the mechanism of action of ZF motifs within tapRNAs
is related to the presence of similar ZF motifs and DNA
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bound proteins at enhancers and on chromatin topol-
ogy. In this way, tapRNA ZF motifs could include the
sequestration or delivery of ZF factors to enhancers, for
example involving the formation of RNA-DNA hybrids
or triplex structures (Mondal et al., 2015; O’Leary et
al., 2015). In all these scenarios, the tapRNAs could
have a positive eﬀect on the transcription of the associ-
ated developmental coding gene, depending on whether
the ZF transcription factor is an activator or repressor
of transcription. Binding of the YY1 transcription fac-
tor to RNA has recently been demonstrated to play a
role at enhancers (Sigova et al., 2015), supporting the
argument that RNA-transcription factor interactions
may inﬂuence enhancer activity.
3.6 The “extended gene” concept in
regulatory evolution
Positionally conserved RNAs deﬁned here include a
number of well-characterized lncRNAs (such as XIST,
H19, AIRN, andMEG3), as well as more recently char-
acterized syntenic RNAs (HOXA13-AS, HOXA1-AS,
EVF2/DLX6OS, NKX2-1-AS and DEANR1/FOXA2-
DS-S) linked to genes with important developmental
roles. These examples and the data presented here
conform to a principle where coding and noncoding
genes and associated regulatory sequences have evolved
in a manner that favors genomic association and co-
expression, and in which the noncoding RNA can have
a role in the regulation of the coding gene (and some-
times vice-versa) and related developmental pathways.
The reason for such apparent co-evolution may be
that the more evolutionary plastic lncRNAs and as-
sociated cis-regulatory elements – with diﬀerent evo-
lutionary constrains compared to protein coding se-
quences - may act as substrates for the alteration of
regulatory functions, which might provide advantages
in determining a new developmental direction. Thus,
positional conservation may deﬁne examples of an “ex-
tended gene” paradigm, where a lncRNA gene and its
associated regulatory elements are linked in genomic
position and function to a coding gene. We believe
there may be many more instances of lncRNA loci in-
volved in an extended gene structure besides the ones
outlined in this work, as our analysis is inherently lim-
ited to a particular subset of syntenic spliced lncRNAs
with conserved promoters and excludes numerous lncR-
NAs that do not meet our inclusion criteria, for exam-
ple single exon or more clade-restricted transcripts and
promoters.
Regardless of these limitations, our current analy-
sis shows that only a small fraction (3%) of protein-
coding genes have positionally conserved RNAs and
that tapRNAs represent a large proportion of these.
The fact that positional conservation identiﬁes RNAs
at topological anchor points, strongly suggests that the
conservation is reﬂective of chromatin architectural fea-
tures or mechanisms to regulate them. This type of
architectural control may be particularly important for
the expression of developmental genes and its regula-
tory dynamics across evolution.
4 Methods
4.1 pcRNA cloning
Cloning of human full-length HNF1A-BT1 transcript
was performed using Gateway Technology (Thermo
Fisher Scientiﬁc, cat. no. 12535-019) according to
the manufacturer’s instructions. Brieﬂy, 2μg total
RNA from HepG2 cells was reverse transcribed in 20μl
reaction using Superscript III Reverse Transcriptase
(Invitrogen; cat. no. 18080044). Touchdown-PCR
was performed using 2μl of the cDNA, mixed with
38.75μl water, 1μl of each primer (10μM) (Supplemen-
tary Table S7), 1.25μl dNTP (10mM), 5μl 10x Pfu Ul-
tra reaction buﬀer and 1μl Pfu Polymerase (Strata-
gene; cat. no. 600380). PCR was performed in the
following conditions: (i) 98C for 30s, (ii) 98C for
10s, (iii) 70-50C for 30s, (iv) 72C for 3min (with
20 cycles repeating steps (ii) - (iv), thereby decreas-
ing the temperature of step (iii) 1C per cycle); fol-
lowed by (v) 98C for 10s, (vi) 50C for 30s, (vii)
72C for 2min, (viii) 72C for 5min, with 15 cycles
repeating steps (v)-(vii). Nested PCR was performed
with PCR products after gel extraction and 1:100 dilu-
tion. The cycling conditions were: (i) 98C for 30s,
(ii) 98C for 10s, (iii) 59C for 30s, (iv) 72C for
2min, (v) 72C for 5 min, with 30 cycles repeating
steps (ii)-(iv). Gel puriﬁed PCR products were quan-
tiﬁed and transferred into the pDONR221 entry vec-
tor (Life Technologies, cat. no. 12536-017). Trans-
formations were performed according to the Gateway
clonase protocol using Escherichia coli DH5α and the
plasmids used in an LR reaction to generate the ex-
pression vectors using the LINC-EXPRESS plasmid
(modiﬁed pLENTI6.3/TO/V5-DEST, kindly provided
by John Rinn (Hacisuleyman et al., 2014).
4.2 Cloning of shRNAs
Short hairpin (sh)RNA design was performed us-
ing the Broad Institute RNAi Consortium software
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(http://www.broadinstitute.org/rnai/public/
seq/search), which was used to select three or four
diﬀerent candidate shRNAs per pcRNA. We tested
their knockdown eﬃciencies in transient transfections
and the eﬀective shRNAs as well as negative control
were used in subsequent experiments (Supplementary
Table S7). Cloning of the annealed shRNA oligos into
pLKO vectors for shRNA Constructs was performed
as described in the TRC Laboratory Protocol (Version
2/12/2013). Brieﬂy, HPLC-puriﬁed oligomers were an-
nealed using ﬁnal concentrations of 3μM each in 1xNEB
buﬀer 2 and used in ligations into pLKO vectors di-
gested with AgeI and EcoRI (pLKO.1 puro (addgene
#8453; (Stewart et al., 2003)) and Tet-pLKO-puro
(addgene #21915; (Wiederschain et al., 2009)). Liga-
tion products were used for transformations of E. coli
DH5α and plasmids were puriﬁed and sequenced.
4.3 Cell culture
Cell lines (Supplementary Table S7) were acquired from
ATCC and cultured at 37C and 5% CO2 in the rec-
ommended media unless speciﬁed. Human hepato-
cellular carcinoma cells Huh-7 and HepG2 cells were
grown in growth medium (Dulbecco’s modiﬁed Eagle’s
medium (DMEM), 10% fetal bovine serum (FBS), 2
mM L-glutamine, 50 ug/ml penicillin and 50 ug/ml
streptomycin) at 37C and 5% CO2. Lung adeno-
carcinoma, Osteosarcoma and glioblastoma cells A549,
U2OS and U251MG were cultured in DMEM supple-
mented with 10% FBS. Mouse embryonic stem cells
(E14) were cultured in 1% gelatin-coted dishes in
DMEM media with 2mM glutamine, 1mM sodium
pyruvate, 1X non-essential amino acids, 10% FBS,
0.1 mM 2-mercaptoethanol, and supplemented with
1,000 U/mL LIF (ESGRO). Human teratocarcinoma
NT2/D1 cells were cultured in DMEM supplemented
with 10% FBS.
For induction NT2 cells and mESCs in media with-
out LIF were treated with 10μM all-trans retinoic acid
(Sigma R 2625) and harvested at diﬀerent time points.
4.4 Knock-down
SiRNA oligonucleotides were ordered from Thermo
Fisher Scientiﬁc (Supplementary Table S7). For over-
expression of coding genes, plasmids were ordered from
Origene (Supplementary Table S7). Transfections for
siRNA-mediated knock-down experiments were per-
formed according to the Lipofectamine RNAiMAX
(Thermo Fisher Scientiﬁc, cat. no. 13778150) proce-
dure. Brieﬂy, the day before transfection 1 × 105 cells
were seeded in 2.5ml DMEM/10% FBS in 6-well plates.
For each well, 50nM siRNA duplexes were diluted in
250μl Opti-MEM. 5μl Lipofectamine RNAiMAX were
added to 245μl Opti-MEM and combined with the
siRNA mix. After incubation for 10-20min at room
temperature (RT) the mix was added drop-wise to the
cells. Cells were incubated for 48h until harvest. For
over-expression, the day before transfection 1 × 105
cells were plated per 6-well in 2ml growth medium with-
out antibiotics. Transfections were performed following
the Fugene6 Transfection Reagent Protocol (Promega,
cat. no. E2691). Brieﬂy, 185μl medium were pre-
mixed with 5μl transfection reagent per well in a 6-well
plate. After 5min incubation at RT, 10μl plasmid DNA
(1μg) were added to the mix and incubated for 30min at
RT. Subsequently the transfection reagent/DNA mix-
ture was added dropwise to each well. The transfected
cells were incubated for 48h before processing.
4.5 RNA isolation and RT-PCR expression
analysis
RNA from cell cultures was puriﬁed using Qiazol (In-
vitrogen) and RNeasy Mini Kit (Qiagen) or Direct-zol
RNA MiniPrep kit (Zymo Research, cat. no. R2072)
and treated with DNase I (Invitrogen), according to
manufacturers’ instructions. Puriﬁed tissue RNA was
purchased from Ambion (FirstChoice Human Total
RNA Survey Panel, cat. no. AM6000) and Clontech
(Mouse Total RNA Master Panel, cat. no. 636644)
(Supplementary Table S7). RNA quality assessed us-
ing the 2100 Bioanalyzer (Agilent Technologies) prior
to further use. cDNA preparation and quantitative
real-time PCR (qPCR) analysis were performed as pre-
viously described (Dinger et al., 2008). Each exper-
iment was performed in at least two biological repli-
cates. Primers were designed spanning splice sites in
most cases and for normalization of transcript expres-
sion levels, B2M, ALAS1 or GAPDH primers were used
(Supplementary Table S7).
4.6 Invasion-migration assays
2.5 × 104 cells were plated in serum-free media in in-
sert plate upper chamber with either non- or Matrigel-
coated membranes (24-well insert; pore size, 8 μm; BD
Biosciences cat. no. 354578 and 354480) for trans-
well migration and invasion assay, respectively. The
bottom chamber contained DMEM with 10% FBS. Af-
ter 24h, the bottom of the chamber insert was ﬁxed
and stained with crystal violet and cells on the stained
membrane were counted under a microscope. Each
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membrane was divided into four quadrants, and an av-
erage from all four quadrants was calculated. Each
assay was performed in biological triplicates.
5 Accession numbers
The microarray data have been submitted to ArrayEx-
press under the accession number: E-MTAB-4517.
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